Teva's market cap is currently 94.48B. The company's EPS TTM is 254.1; its P/E ratio is 41.15; Teva is scheduled to report earnings on November 5, 2025, and the estimated EPS forecast is 217.10. See an overview of income statement, balance sheet, and cash flow financials.
